Bacteremia in young urban women admitted with pyelonephritis

American Journal of the Medical Sciences

Volumn 313, Issue 1, 1997, Pages 50-57

  Smith, Wally R ^a,c   McClish, Donna K ^a   Poses, Roy M ^a   Pinson, Andy G ^a   Miller, Stephen T ^b   Bobo Moseley, Loretta ^b   Morrison, Robert E ^b   Lancaster, Daniel J ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c Box 980306 ^*  (United States)

Author keywords

Bacteremia; Pyelonephritis; Urinary tractinfection; Women

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTEREMIA; BLOOD CULTURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; PREGNANCY COMPLICATION; PYELONEPHRITIS; RETROSPECTIVE STUDY; RISK FACTOR; URINARY TRACT INFECTION;

EID: 0031014099     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199701000-00008     Document Type: Article

References (26)

1. Tamm WE, Hooton TM, Johnson JR, Johnson C, Sta- pleton A, Roberts PL, et al. Urinary tract infections: From pathogenesis to treatment. J Infect Dis. 1989;159:400-6.
2. Gleckman RA. Treatment duration for urinary tract infections in adults. Antimicrob Agents Chemother. 1987;31:1-5.
3. Kreger BE, Craven DE, Carting PC, McCabe WR. Gram- negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med. 1980;68:332-43.
4. McCabe WR. Antibiotics and endotoxic shock. Bull NY Acad Med. 1975;51:1084.
5. Grover SA, Komaroff AL, Weisberg M, Cook EF, Goldman L. The characteristics and hospital course of patients admitted for presumed acute pyelonephritis. J Gen Intern Med. 1987;2:5-10
6. Gleckman R, Bradley P, Roth R, Hibert D, Pelletier C. Therapy of symptomatic pyelonephritis in women. J Urol. 1985;133:176-8.
7. Johnson JR, Lyons MF 2d, Pearce W, German P. Roberts PL, White N, et al. Therapy for women hospitalized with acute pyelonephritis: A randomized trial of ampicillin versus trimethoprim-sulfamethoxazole for 14 days. J Infect Dis. 1991;163:325-30.
8. Sanders CV, Marier RL, Aldridge KE, Derks FW, Martin DH. Safety and effectiveness of ticarcillin plus clavulanic acid in the treatment of community-acquired acute pyelonephritis in adult women. Am J Med. 1985;79(suppl 5B):96-100.
9. Safrin S, Siegel D, Black D. Pyelonephritis in adult women: Inpatient versus outpatient therapy. Am J Med. 1988; 85:793-8.
10. Sandberg T, Englund G, Lincoln K, Nilsson LG. Randomised double-blind study of norfloxacin and cefadroxil in the treatment of acute pyelonephritis. Eur J Clin Microbiol Infect Dis. 1990;9:317-23.
11. June CH, Browning MD, Smith LP, Wenzel DJ, Pyatt RS, Checchio LM, Amis ES. Ultrasonography and computed tomography in severe urinary tract infection. Arch Intern Med. 1985;145:841-5.
12. McMurdock J, Speirs CF, Geddes AM, et al. Treatment of recurrent urinary tract infection. In: O'Grady FO, Brumfitt W; eds. Urinary Tract Infection. London: Oxford Press; 1968:227-34.
13. Gleckman R, Blagg N, Hibert D, Hall A, Crowley M, Pritchard A, Warren W. Acute pyelonephritis in the elderly. South Med J. 1982;75:551-4.
14. Gleckman R, Blagg N, Hibert D, Hall A, Crowley M, Pritchard A, Warren W. Community-acquired bacteremic urosepsis in the elderly patients: A prospective study of 34 consecutive episodes. J Urol. 1982;128:79-81.
15. Hart CA, Desmond AI, Percival A. Treatment of gontamicin-resistant Klebsiella urinary tract infection with cephradine, augmentin, cefuroxime and amikacin. J Antimicrob Chemother. 1981;118:231-7.
16. Gleckman RA, Bradley PJ, Roth RM, Hibert DM. Bacteremic urosepsis: A phenomenon unique to elderly women. J Urol. 1985;133:174-5.
17. Dolan JG, Bordley DR, Polito R. Initial management of serious urinary tract infection: Epidemiologic guidelines. J Gen Intern Med. 1989;4(3):190-4.
18. Pinson AG, Philbrick JT, Lindbeck GH, Schorling JB; eds. Management of acute pyelonephritis in women: A cohort study. Am J Emerg Med. 1994;12:271-8.
19. Lomberg H, Hanson LA, Jacobsson B, Jodal U, Leffler H, Svanborg-Eden CS. Correlation of P blood group, vesicoureteral reflux, and bacterial attachment in patients with recurrent pyelonephritis. N Engl J Med. 1983;308:1189-92.
20. Jacobson SH, Lins LE, Svenson SB, Kallenius G. P-fimbriated E. coli in adults with acute pyelonephritis. J Infect Dis. 1985;152:426-7.
21. Otto G, Sandberg T, Marklund B-I, Ulleryd P, Svanborg C. Virulence factors and pap genotype in Escherichia Coli isolates from women with acute pyelonephritis, with or without bacteremia. Clin Infect Dis. 1993;17:448-56.
22. Dowling KJ, Roberts JA, Kaack BM. P-Fimbriated Escherichia coli urinary tract infection: A clinical correlation. South Mod J. 1987;80:1533-6.
23. Workowski KA, Suchland RJ, Pettinger MB, Stamm WE. Association of genital infection with specific Chlamydia trachomatis serovars and race. J Infect Dis. 1992;166:1445-9.
24. Rubin RH, Fang LST, Jones SR, et al. Single-dose amoxicillin therapy for urinary tract infection. JAMA, 1980; 244:561-4.
25. Platt R. Diagnosis and empiric therapy of urinary tract infection in the seriously ill patient. Review of Infectious Disease. 1983;5(suppl 1):S65-73.
26. Bates DW, Cook EF, Goldman L, Lee TH. Predicting bactoremia in hospitalized patients: A prospectively validated model. Ann Intern Med. 1990;113:495-500.